These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Science resources. Chemists want NIH to curtail database. Kaiser J. Science; 2005 May 06; 308(5723):774. PubMed ID: 15879180 [No Abstract] [Full Text] [Related]
26. Methyl protogracillin (NSC-698792): the spectrum of cytotoxicity against 60 human cancer cell lines in the National Cancer Institute's anticancer drug screen panel. Hu K, Yao X. Anticancer Drugs; 2001 Jul 06; 12(6):541-7. PubMed ID: 11460001 [Abstract] [Full Text] [Related]
28. Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities. Rabow AA, Shoemaker RH, Sausville EA, Covell DG. J Med Chem; 2002 Feb 14; 45(4):818-40. PubMed ID: 11831894 [Abstract] [Full Text] [Related]
36. Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. Bykov VJ, Issaeva N, Selivanova G, Wiman KG. Carcinogenesis; 2002 Dec 12; 23(12):2011-8. PubMed ID: 12507923 [Abstract] [Full Text] [Related]